Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
SC17 - Lung Cancer: A Global Cancer with Different Regional Challenges
- Type: Science Session
- Track: Regional Aspects/Health Policy/Public Health
- Presentations: 6
- Moderators:C. Vallejos
- Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 1
-
+
SC17.01 - Lung Cancer in Russia: Challenges and Perspectives
14:20 - 14:35 | Author(s): V. Gorbunova
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC17.02 - Lung Cancer in China: Challenges and Perspectives
14:35 - 14:50 | Author(s): L. Zhang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC17.03 - Lung Cancer in India: Challenges and Perspectives
14:50 - 15:05 | Author(s): D. Behera
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC17.04 - Lung Cancer in Latin America: Challenges and Perspectives
15:05 - 15:20 | Author(s): E. Richardet
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC17.05 - Lung Cancer in Africa: Challenges and Perspectives
15:20 - 15:35 | Author(s): R.M. Gaafar
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
SC17.06 - Lung Cancer in Low and Middle Income Countries: A Comprehensive Cancer Control Approach
15:35 - 15:50 | Author(s): N. Enwerem-Bromson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
IASLC Business Meeting
- Type: Networking Opportunity
- Track:
- Presentations: 2
- Coordinates: 12/06/2016, 14:30 - 15:00, Schubert 2
-
+
WCLC 2016 Business Meeting Awards
14:30 - 14:50 | Author(s): F.R. Hirsch
- Abstract
No abstract available for this presentation
-
+
Travel Award Winners
14:50 - 15:00 | Author(s): F.R. Hirsch
- Abstract
No abstract available for this presentation
-
+
ED08 - Early-Stage NSCLC: State-of-the-Art Treatment and Perspectives
- Type: Education Session
- Track: Early Stage NSCLC
- Presentations: 4
- Moderators:T. Le Chevalier
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall C2
-
+
ED08.01 - Surgery of Early-Stage NSCLC
14:30 - 14:50 | Author(s): M.R. Mueller
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED08.02 - The Role of Radiotherapy in Early-Stage NSCLC
14:50 - 15:10 | Author(s): S. Senan
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED08.03 - Adjuvant Chemotherapy of Completely Resected
15:10 - 15:30 | Author(s): G. Goss
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED08.04 - Perspectives of Targeted Therapies and Immunotherapy in Completely Resected NSCLC
15:30 - 15:45 | Author(s): H. Wakelee
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ED09 - Advances in Lung Cancer Screening
- Type: Education Session
- Track: Radiology/Staging/Screening
- Presentations: 4
- Moderators:C. Berg
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall C8
-
+
ED09.01 - Radiological Advances in Lung Cancer Screening
14:30 - 14:50 | Author(s): M. Prokop
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED09.02 - Risk Prediction Modelling in Lung Cancer Screening Programs
14:50 - 15:10 | Author(s): M. Tammemägi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
ED09.03 - Overdiagnosis in Lung Cancer Screening
15:10 - 15:30 | Author(s): C.A. Powell
- Abstract
No abstract available for this presentation
Information from this presentation has been removed upon request of the author.
-
+
ED09.04 - Cost Effectiveness of CT Screening
15:30 - 15:45 | Author(s): B. Pyenson
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
NU04 - Managing Toxicity
- Type: Nurses Session
- Track: Nurses
- Presentations: 4
- Moderators:M. Hesdorffer
- Coordinates: 12/06/2016, 14:30 - 15:45, Schubert 5
-
+
NU04.01 - Management of Toxicities Associated with Immunotherapy in the Lung Cancer Patients
14:30 - 14:50 | Author(s): M. Davies
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
NU04.02 - Experience of Lung Cancer Patients Receiving Immunotherapy
14:50 - 15:10 | Author(s): R. Thomas
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
NU04.03 - Where are we With TKI Toxicities
15:10 - 15:30 | Author(s): B. Eaby-Sandy
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
NU04.04 - Q&A
15:30 - 15:45
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Biology/Pathology
- Presentations: 94
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.01-001 - Enrichment-Free, Rapid Metabolic Assay for Detection of Tumor Cells in Pleural Effusion and Pheripheral Blood
14:30 - 14:30 | Author(s): Q. Shi
- Abstract
Loading... -
+
P2.01-002 - Serum Protein Signature in Lung Cancer Patients and in Patients with Chronic Obstructive Pulmonary Disease
14:30 - 14:30 | Author(s): J. Berg
- Abstract
Loading... -
+
P2.01-003 - Serum VEGF, MMP-7 and CYFRA 21-1 as Predictive Markers of Lung Metastases from Colorectal Cancer
14:30 - 14:30 | Author(s): F. Lumachi
- Abstract
Loading... -
+
P2.01-004 - The Methylation Profiling of Multiple Tumor Suppressor Genes in Plasma Cell-Free DNA of Patients with NSCLC vs Benign Tumors
14:30 - 14:30 | Author(s): M. Florczuk
- Abstract
Loading... -
+
P2.01-005 - Evaluation of Circulating Tumoral Microemboli (CTM) as a Prognostic Factor in Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): M. Corassa
- Abstract
Loading... -
+
P2.01-006 - Sensitive Detection of CTCs in Thoracic Malignant Tumors With "Universal" CTC-Chip
14:30 - 14:30 | Author(s): K. Yoneda
- Abstract
Loading... -
+
P2.01-007 - Detection of Promoter DNA Methylation of APC, DAPK, and GSTP1 Genes in Tissue Biopsy and Matched Serum of Advanced Stage Lung Cancer Patients
14:30 - 14:30 | Author(s): A.A. Ansari
- Abstract
Loading... -
+
P2.01-008 - SiRe Next Generation Sequencing Panel: Effective Diagnostic Tool for Circulating Free DNA Analysis
14:30 - 14:30 | Author(s): U. Malapelle
- Abstract
Loading... -
+
P2.01-009 - Serial Quantitative Assessment of Plasma Circulating Tumor DNA by Digital NGS in Patients with Lung Cancer
14:30 - 14:30 | Author(s): Y. Zhao
- Abstract
Loading... -
+
P2.01-010 - Downregulation of PFTK1 by shRNA Inhibits Migration and Invasion of Human Non-Small Cell Lung Cancer Cell Lines
14:30 - 14:30 | Author(s): W. Yue
- Abstract
Loading... -
+
P2.01-011 - Identification of Differentially Expressed Circulating miRNAs in the Serum of NSCLC Patients Using next Generation Sequencing
14:30 - 14:30 | Author(s): S. Kumar
- Abstract
Loading... -
+
P2.01-012 - Acquired Chemotherapy Resistance in vitro: miRNA Profiles of Chemotherapy Resistant Squamous Lung Cancer Cell Lines
14:30 - 14:30 | Author(s): S.A. Haefliger
- Abstract
Loading... -
+
P2.01-013 - HA-Liposome Nanocarrier Containing CD44 siRNA as a Targeted Chemotherapy to CD44 Related Chemoresistant Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H.K. Kim
- Abstract
Loading... -
+
P2.01-014 - miR-3941: A Novel microRNA That Controls IGBP1 Expression and is Associated with Malignant Progression of Lung Adenocarcinoma
14:30 - 14:30 | Author(s): T. Sato
- Abstract
Loading... -
+
P2.01-015 - Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes
14:30 - 14:30 | Author(s): T. Tokar
- Abstract
Loading... -
+
P2.01-016 - Analysis of 5 Differential miRNA Expression in NSCLC Patients
14:30 - 14:30 | Author(s): M.A. Lewandowska
- Abstract
Loading... -
+
P2.01-017 - Circulating miRNAs in Lung Cancer Are Associated to Pro-Tumorigenic and Immunosuppressive Microenvironment
14:30 - 14:30 | Author(s): O. Fortunato
- Abstract
Loading... -
+
P2.01-018 - Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients
14:30 - 14:30 | Author(s): M. Giordano
- Abstract
Loading... -
+
P2.01-019 - Three microRNAs Associated with Poor Prognosis Are Up-Regulated in Amplified Regions of Squamous Cell Lung Carcinoma
14:30 - 14:30 | Author(s): S. Yokoi
- Abstract
Loading... -
+
P2.01-020 - Identification of a Three-lncRNA Signature for Lung Cancer Diagnosis and Prognosis
14:30 - 14:30 | Author(s): B. Zhang
- Abstract
Loading... -
+
P2.01-021 - miRNA Deep Sequencing of Early-Stage Lung Cancer Patients to Evaluate the Dynamic Change of Circulating Biomarkers in Response to Surgery
14:30 - 14:30 | Author(s): D. Petriella
- Abstract
Loading... -
+
P2.01-022 - A PIWI-Interacting RNAs Co-Expression Networks as a Prognostic Factor in Lung Cancer
14:30 - 14:30 | Author(s): B.C. Minatel
- Abstract
Loading... -
+
P2.01-023 - Deregulation of Small Non-Coding RNAs at the DLK1-DIO3 Imprinted Locus Predicts Lung Adenocarcinoma Patient Outcome
14:30 - 14:30 | Author(s): J.R. Enterina
- Abstract
Loading... -
+
P2.01-024 - Expression of miR-106 Paralogs Improves Prognostic Value of Mesenchymal Signatures but Only miR-106b Promotes Invasiveness
14:30 - 14:30 | Author(s): S.H.Y. Kung
- Abstract
Loading... -
+
P2.01-025 - MiR-146b Functions as a Suppressor miRNA and Prognosis Predictor in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Chen
- Abstract
Loading... -
+
P2.01-026 - A Mass Spectrometry Based Stem Cell-Oriented Phylogeny of Intra-Tumoral NSCLC Subclones
14:30 - 14:30 | Author(s): R.J. Downey
- Abstract
Loading... -
+
P2.01-027 - A Comparison of Five Different Immunohistochemistry Assays for Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer Samples
14:30 - 14:30 | Author(s): R. Soo
- Abstract
Loading... -
+
P2.01-028 - Prognostic Significance of GLUT1 and CAIX Expression: Correlation with Volume-Based PET Parameters in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): Y.W. Koh
- Abstract
Loading... -
+
P2.01-029 - Tumor B7-H3 (CD276) Protein Expression, Smoking History, and Survival in Lung Adenocarcinoma Patients
14:30 - 14:30 | Author(s): K. Inamura
- Abstract
Loading... -
+
P2.01-030 - Prognostic Impact of Stathmin1 Expression in Patients with Non-Small Lung Cancer
14:30 - 14:30 | Author(s): K. Shimizu
- Abstract
Loading... -
+
P2.01-031 - CCL Chemokines May Play an Important Role in Cisplatin Resistance
14:30 - 14:30 | Author(s): S. Ryan
- Abstract
Loading... -
+
P2.01-032 - Impact of Preoperative Serum Anti-60S Ribosomal Protein L29 Levels on Prognosis in Patients Who Underwent Surgery for Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Yamamoto
- Abstract
Loading... -
+
P2.01-033 - Exosomal Proteomics Analysis Reveal New Targets for Radiation-Induced Lung Toxicity Diagnosis
14:30 - 14:30 | Author(s): X. Jin
- Abstract
Loading... -
+
P2.01-034 - The Pregnancy Associated Endometrial Protein Glycodelin as a Biomarker for Malignant Pleural Mesothelioma
14:30 - 14:30 | Author(s): M.A. Schneider
- Abstract
Loading... -
+
P2.01-035 - Protein and Molecular Alterations in EMT Pathways of Lung Cancer: A Comparative Analysis between NSCLCs
14:30 - 14:30 | Author(s): J.R. Machado
- Abstract
Loading... -
+
P2.01-036 - Identification of a Novel Oncogenic Ubiquitin Ligase from a Lung Cancer Epigenome-Wide Association Study (EWAS)
14:30 - 14:30 | Author(s): C. Faltus
- Abstract
Loading... -
+
P2.01-037 - Molecular Biology Underlying COPD and Lung Cancer Converge on FOXM1 Network
14:30 - 14:30 | Author(s): V.D. Martinez
- Abstract
Loading... -
+
P2.01-038 - Discrimination of NSCLC Cases from Cancer-Free Controls and Adenocarcinoma from Squamous Cell Carcinoma Using Plasma Metabolomics Profiles
14:30 - 14:30 | Author(s): J.O. Kim
- Abstract
Loading... -
+
P2.01-039 - Prognostic Significance of Claudin Protein Expression in Histological Subtypes of Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Moldvay
- Abstract
Loading... -
+
P2.01-040 - CXC Chemokine Receptor 3 and ELR Motif Negative CXC Chemokine Ligand Axis in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Spaks
- Abstract
Loading... -
+
P2.01-041 - Integrated Proteo-Genomics Analyses Reveal Extensive Tumor Heterogeneity and Novel Somatic Variants in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): R. Biswas
- Abstract
Loading... -
+
P2.01-042 - T Cells Subsets with INF-Gamma, TNF-Alpha and ADA in Distinguishing Tuberculous from Malignant Pleural Effusions
14:30 - 14:30 | Author(s): A. Ali
- Abstract
Loading... -
+
P2.01-043 - Pathologist Agreement Rates of PD-L1 Tumor and Immune Cell Quantitation Using Digital Read, Field-Of-View, and Whole Tumor Image Analysis
14:30 - 14:30 | Author(s): M. Barnes
- Abstract
Loading... -
+
P2.01-044 - Baseline Peripheral Blood Cell Subsets Associated with Survival Outcomes in Advanced NSCLC Treated with Nivolumab in Second-Line Setting
14:30 - 14:30 | Author(s): A. Passaro
- Abstract
Loading... -
+
P2.01-045 - Nintedanib Improves Anti-Tumor Efficacy in Combination with Anti PD-1 in Syngeneic Tumor Models Sensitive and Refractory to IO Inhibition
14:30 - 14:30 | Author(s): F. Hilberg
- Abstract
Loading... -
+
P2.01-046 - Quantitative Measurement of B7-H3 Protein Expression and Its Association with B7-H4, PD-L1 and TILs in NSCLC
14:30 - 14:30 | Author(s): M. Altan
- Abstract
Loading... -
+
P2.01-047 - Intra- and Inter-Observer Reproducibility Study of PD-L1 Biomarker in Non-Small Cell Lung Cancer (NSCLC) - The DREAM STUDY
14:30 - 14:30 | Author(s): W.A. Cooper
- Abstract
Loading... -
+
P2.01-048 - Paired Comparison of PDL1 Assessment on Cytology and Histology from Malignancies in the Lung
14:30 - 14:30 | Author(s): B.G. Skov
- Abstract
Loading... -
+
P2.01-049 - A Comparative Study of PD-L1 IHC 28-8 pharmDx and PD-L1 IHC 22C3 pharmDx on Malignancies from the Lung
14:30 - 14:30 | Author(s): B.G. Skov
- Abstract
Loading... -
+
P2.01-050 - Clinicopathological Characteristics of PD-L1 Expression in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): S. Wu
- Abstract
Loading... -
+
P2.01-051 - Myeloid-Derived Suppressor Cell Expression within the Microenvironment of Lung Adenocarcinoma
14:30 - 14:30 | Author(s): Y. Jin
- Abstract
Loading... -
+
P2.01-052 - High PD-L1 Expression is Associated with Worse Prognosis in Primary Resected Squamous Cell Carcinomas of the Lung
14:30 - 14:30 | Author(s): M. Keller
- Abstract
Loading... -
+
P2.01-053 - PD-L1 Expression in Patients with Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Wang
- Abstract
Loading... -
+
P2.01-054 - Lung Cancer PD-L1 mRNA Expression Profile and Clinical Outcomes - An Analysis From The Cancer Genome Atlas and Cancer Cell Line Encyclopedia
14:30 - 14:30 | Author(s): J. Roszik
- Abstract
Loading... -
+
P2.01-055 - Lymphocytes' Subtypes Differentiation after Stimulation with Synthetic Antigen-Pulsed Dendritic Cells in Lung Adenocarcinoma Patients
14:30 - 14:30 | Author(s): K. Wojas-Krawczyk
- Abstract
Loading... -
+
P2.01-056 - Distinct PD-L1 Expression in Different Components of Pulmonary Sarcomatoid Carcinoma and Its Association with MET Mutation
14:30 - 14:30 | Author(s): J. Sharma
- Abstract
Loading... -
+
P2.01-057 - Association of Tumor Infiltrating Lymphocytes Quantification with EGFR Mutations in Completely Resected Stage IIIA(N2) Lung Adenocarcinoma
14:30 - 14:30 | Author(s): W. Feng
- Abstract
Loading... -
+
P2.01-058 - Mutational Features Associated with Immunoreactivity in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): N. Syn
- Abstract
Loading... -
+
P2.01-059 - Regulation of Glycodelin Expression - An Immunomodulatory and Pregnancy Associated Protein in NSCLC
14:30 - 14:30 | Author(s): R. Weber
- Abstract
Loading... -
+
P2.01-060 - Comparative Analysis of PD-L1 Expression between Circulating Tumor Cells and Tumor Tissues in Patients with Lung Cancer
14:30 - 14:30 | Author(s): Y. Koh
- Abstract
Loading... -
+
P2.01-061 - Image Analysis-Based Expression of Nine Immune Checkpoints Identifies Distinct Immunoprofiling Patterns in Non-Small Cell Lung Carcinomas
14:30 - 14:30 | Author(s): E.R. Parra
- Abstract
Loading... -
+
P2.01-062 - Impact of the Tissue Distribution of Subpopulations of TILs and PD-L1 Expression on the Clinical Outcome of NSCLC
14:30 - 14:30 | Author(s): G. Bocchialini
- Abstract
Loading... -
+
P2.01-063 - PDL1, JAK2 and PTEN Copy Number Alterations Synergistically Upregulate PD-L1 Expression in NSCLC
14:30 - 14:30 | Author(s): S. Clavé
- Abstract
Loading... -
+
P2.01-064 - Molecular Context of Immune Microenvironment in Early-Stage Lung Squamous Cell Carcinoma
14:30 - 14:30 | Author(s): E. Conde
- Abstract
Loading... -
+
P2.01-065 - Quantification of Tumour-Immune Cell Spatial Relationships in the Lung Tumour Microenvironment Using Single Cell Profiling
14:30 - 14:30 | Author(s): K.S.S. Enfield
- Abstract
Loading... -
+
P2.01-066 - PD-L1 Tumor Expression and Its Effect on Overall Survival among Patients with Resected Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): J.S.Y. Sui
- Abstract
Loading... -
+
P2.01-067 - The Relevance of CEA and CYFRA21-1 as Predictive Factors in Nivolumab Treated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
14:30 - 14:30 | Author(s): M.G. Dal Bello
- Abstract
Loading... -
+
P2.01-068 - Analysis of Epithelial-Stromal Interactions and their Relevance to Lung Cancer
14:30 - 14:30 | Author(s): C. Márquez
- Abstract
Loading... -
+
P2.01-069 - Erythron Reaction Shows High Malignant Tumor Process in Lung Cancer Patients
14:30 - 14:30 | Author(s): Y. Ragulin
- Abstract
Loading... -
+
P2.01-070 - Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): N. Wyatt
- Abstract
Loading... -
+
P2.01-071 - Biological Implication of Cytoplasmic ECT2 in Malignant Progression of Lung Adenocarcinoma
14:30 - 14:30 | Author(s): Z. Kosibaty
- Abstract
Loading... -
+
P2.01-072 - Clinical Associations of MUC1 Expression in Human Lung Cancer and Precancerous Lesions
14:30 - 14:30 | Author(s): A. Saltos
- Abstract
Loading... -
+
P2.01-073 - The Diagnostic Value of Carcinoembryonic Antigen and Squamous Cell Carcinoma Antigen in Lung Adenosquamous Carcinoma
14:30 - 14:30 | Author(s): H. Lu
- Abstract
Loading... -
+
P2.01-074 - Increased AIMP2-DX2/AIMP2 Autoantibody Ratio is Associated with Poor Prognosis in Lung Cancer
14:30 - 14:30 | Author(s): E.Y. Kim
- Abstract
Loading... -
+
P2.01-075 - Prognostic Value of Angiogenesis and Cell Adhesion Biomarkers in Non-small Cell Lung Cancer
14:30 - 14:30 | Author(s): K. Syrigos
- Abstract
Loading... -
+
P2.01-076 - Drebrin: A New Targetable Molecular Marker of Lung Adenocarcinoma
14:30 - 14:30 | Author(s): S. Iyama
- Abstract
Loading... -
+
P2.01-077 - Serum CYFRA 21-1 and CEA Level as a Predicting Marker for Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): B. Chewaskulyong
- Abstract
Loading... -
+
P2.01-078 - Frequent High TIM-3 (HAVCR2) Expression in Resected NSCLC Specimens, Most Notably in Adenocarcinoma Histology
14:30 - 14:30 | Author(s): A. Lisberg
- Abstract
Loading... -
+
P2.01-079 - The Serum Levels of Alpha-1 Antitrypsin Are Strongly Associated with Its Local Production by Tumor Cells in NSCLC Patients
14:30 - 14:30 | Author(s): A. Szpechcinski
- Abstract
Loading... -
+
P2.01-080 - Mitosis Count of Lung Adenocarcinomas: Correlation between the Phosphorylated Histone 3, Number of Cancer Cells, Nuclear Grade, and Prognosis
14:30 - 14:30 | Author(s): T. Inoue
- Abstract
Loading... -
+
P2.01-081 - CDCA3 is a Novel Prognostic Cell Cycle Protein and Target for Therapy in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M.N. Adams
- Abstract
Loading... -
+
P2.01-082 - Transcriptional Profiling Identified the Anti-Proliferative Effect of Mitofusin-2 Deficiency and Its Risk in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): Y. Lou
- Abstract
Loading... -
+
P2.01-083 - Prognostic Factors of Overall Survival in 150 Resected Lung Adenocarcinoma Patients
14:30 - 14:30 | Author(s): Y. Cheng
- Abstract
Loading... -
+
P2.01-084 - Linker-Phosphorylated Smad2 and STAT3 Induce Resistance to Tyrosine Kinase Inhibition in Lung Cancer
14:30 - 14:30 | Author(s): Y. Makino
- Abstract
Loading... -
+
P2.01-085 - Epigenetic Profile of Oligoprogressive versus Widespread Non-Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): C. Gabay
- Abstract
Loading... -
+
P2.01-086 - Luteolin is a Novel Target of Axl Receptor Tyrosine Kinase to Inhibit Cell Proliferation and Circumvent Chemoresistance in Lung Cancer Cells
14:30 - 14:30 | Author(s): K. Kim
- Abstract
Loading... -
+
P2.01-087 - Prognostic Significance of CA IX Overexpression in Stage III NSCLC Patients Received Neoadjuvant Treatment
14:30 - 14:30 | Author(s): S. Saglam
- Abstract
Loading... -
+
P2.01-088 - Prenylation Inhibitors in Lung Adenocarcinoma: Comparison of Zoledronic Acid and a Novel Lipophilic Bisphosphonate
14:30 - 14:30 | Author(s): E. Molnar
- Abstract
Loading... -
+
P2.01-089 - Predictive Value of AEG-1 Expression on Tumor Response by Liquid Biopsy in NSCLC Patients Treated with Chemotherapy
14:30 - 14:30 | Author(s): Y. Chen
- Abstract
Loading... -
+
P2.01-090 - Platin Induced Phosphorylation of ATM and ATM-Deficiency as a Predictive Marker of Platin Sensitivity in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Moore
- Abstract
Loading... -
+
P2.01-091 - The Anticancer Effect of Techoic Acids on Lewis Lung Carcinoma Model
14:30 - 14:30 | Author(s): V. Nikulina
- Abstract
Loading... -
+
P2.01-092 - PRMT5 is a Poor Prognostic Marker for NSCLC and Inhibition of PRMT5 Results in Increased Lung Cancer Sensitivity to Cisplatin and Radiotherapy
14:30 - 14:30 | Author(s): M.X. Welliver
- Abstract
Loading... -
+
P2.01-093 - Exo-ALK Proof of Concept: Exosomal Analysis of ALK Alterations in Advanced NSCLC Patients
14:30 - 14:30 | Author(s): C. Rolfo
- Abstract
Loading... -
+
P2.01-094 - Stromal Antigen 1 (SA-1), a Cohesin, is a Novel Proto-Oncogene Regulating Chromatin in Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): S. Chowdhury
- Abstract
Loading...
-
+
P2.02 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Locally Advanced NSCLC
- Presentations: 62
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.02-001 - Advanced Large Cell Lung Cancer; Biological Behavior and Prognostic Factors
14:30 - 14:30 | Author(s): H. Aziz
- Abstract
Loading... -
+
P2.02-002 - Association between VEGF Gene Functional Polymorphisms and Clinical and Pathological Characteristics of Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Shchayuk
- Abstract
Loading... -
+
P2.02-003 - Increased Circulating Cytokeratin-19 (Cyfra 21-1) is Predictive of Poor Outcome of Locally Advanced Squamous Cell Carcinoma in Lung
14:30 - 14:30 | Author(s): J. Wang
- Abstract
Loading... -
+
P2.02-004 - Real-time Monitoring of Circulating Tumor Cells to Evaluate Response of Neoadjuvant Chemotherapy in Locally Advanced NSCLC
14:30 - 14:30 | Author(s): M. Huang
- Abstract
Loading... -
+
P2.02-005 - A Rare Clinical Presentation Of EGFR-Mutant Non-Small Cell Lung Cancer With Oligo-Acrometastasis
14:30 - 14:30 | Author(s): P. Akın Kabalak
- Abstract
Loading... -
+
P2.02-006 - Targeted Next Generation Sequencing Reveals Prognostic Recurrent Somatic Mutations in the GNAQ Oncogene in NSCLC
14:30 - 14:30 | Author(s): N.Y. Hernández-Pedro
- Abstract
Loading... -
+
P2.02-007 - Treatment Outcomes of Combine Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Single Institution Study
14:30 - 14:30 | Author(s): P. Klunklin
- Abstract
Loading... -
+
P2.02-008 - How Do We Really Treat Patients with Stage III Non-Small Cell Lung Cancer (NSCLC)?
14:30 - 14:30 | Author(s): A. Price
- Abstract
Loading... -
+
P2.02-009 - Clinical Outcomes of Induction Chemoradiotherapy with High Dose Chest Radiation for Locally Advanced Non-Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): H. Torigoe
- Abstract
Loading... -
+
P2.02-010 - Prognosis Impact of Oligoprogression Following Definitive Chemo-Radiotherapy in Stage III Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Saigi
- Abstract
Loading... -
+
P2.02-011 - Management of Non-Small-Cell Lung Cancer (NSCLC) Stage III Patients in Central European Countries
14:30 - 14:30 | Author(s): M. Zemanová
- Abstract
Loading... -
+
P2.02-012 - Long-Term Survival of Phase II of Full-Dose Oral Vinorelbine Combined with Cisplatin & Radiotherapy in Locally Advanced NSCLC
14:30 - 14:30 | Author(s): Ó. Juan
- Abstract
Loading... -
+
P2.02-013 - Costing Analysis of PROCLAIM Non–Small Cell Lung Cancer Trial Data
14:30 - 14:30 | Author(s): M. Wilson
- Abstract
Loading... -
+
P2.02-014 - Perioperative Outcomes and Downstaging Following Neoadjuvant Therapy For Lung Cancer – Analysis of the National Cancer Database
14:30 - 14:30 | Author(s): S. Atay
- Abstract
Loading... -
+
P2.02-015 - Guideline Concordant Care is Associated with Better Survival for Patients with Stage III Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H.Z. Ahmed
- Abstract
Loading... -
+
P2.02-016 - Real World Experience with Chemoradiotherapy in Locally Advanced NSCLC
14:30 - 14:30 | Author(s): J. Gimeno
- Abstract
Loading... -
+
P2.02-017 - A Clinical Outcome of Resected Small-Sized Non-Small Cell Lung Cancer 1 cm or Less in Diameter with N2 Lymph Node Metastasis
14:30 - 14:30 | Author(s): Y. Kato
- Abstract
Loading... -
+
P2.02-018 - Chemoradiotherapy in Elderly Patients with Locally Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Linhas
- Abstract
Loading... -
+
P2.02-019 - Lung Cancer in Young Adults (Age Group 18-50 yrs): Presentation, Clinical Features and Treatment
14:30 - 14:30 | Author(s): B. Varadhan
- Abstract
Loading... -
+
P2.02-020 - Pattern of Care of Inoperable Locally Advanced (LA) NSCLC in Elderly Patients: Analysis of the Experience of Two Academic Italian Hospitals
14:30 - 14:30 | Author(s): M. Perna
- Abstract
Loading... -
+
P2.02-021 - Extracranial Progression (ePD) after Chemoradiotherapy (CRT) for Stage III NSCLC: Does the Chemotherapy Regimen Matter?
14:30 - 14:30 | Author(s): L. Hendriks
- Abstract
Loading... -
+
P2.02-022 - For down Staged Clinical N3 M0 Non-Small Cell Lung Cancer Patients Chemo-Radiotherapy Followed by Surgery Can Improve Survival
14:30 - 14:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P2.02-023 - Neoadjuvant Chemotherapy and Concurrent Full-Dose Radiation Therapy Followed by Surgery for Stage IIIB Non-Small Cell Carcinoma of the Lung
14:30 - 14:30 | Author(s): S. Yan
- Abstract
Loading... -
+
P2.02-024 - Phase I and II Trial of Intrapleural Paclitaxel Injection for Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusions
14:30 - 14:30 | Author(s): M. Sasaki
- Abstract
Loading... -
+
P2.02-025 - Continuous Intravenous Pumping Endostar Combined with Radiochemotherapy in Unresectable Stage Ⅲ Non-Small-Cell Lung Cancer
14:30 - 14:30 | Author(s): H.L. Ma
- Abstract
Loading... -
+
P2.02-026 - Individualized Adjuvant Chemotherapy for Resected Lung Cancer According to Collagen Gel Droplet-Embedded Culture Drug Sensitivity Test
14:30 - 14:30 | Author(s): M. Inoue
- Abstract
Loading... -
+
P2.02-027 - A Randomized Phase II Trial of S-1 plus Cisplatin or Docetaxel plus Cisplatin with Concurrent Thoracic Radiotherapy for Stage III NSCLC: TORG1018
14:30 - 14:30 | Author(s): K. Yamada
- Abstract
Loading... -
+
P2.02-028 - A Phase I/II Study of Carboplatin, Pemetrexed, and Concurrent Radiation Therapy for Patients with Locally Advanced NSCLC. CJLSG0912
14:30 - 14:30 | Author(s): N. Murata
- Abstract
Loading... -
+
P2.02-029 - Concomitant ChemoRadiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase II Study from the Galician Lung Cancer Group
14:30 - 14:30 | Author(s): S. Gómez
- Abstract
Loading... -
+
P2.02-030 - Consolidation Chemotherapy Following Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: A Brazilian Multicentric Cohort
14:30 - 14:30 | Author(s): V.C. Cordeiro De Lima
- Abstract
Loading... -
+
P2.02-031 - Survival Data of Postoperative Adjuvant Chemotherapy of Cisplatin plus Vinorelbine for Completely Resected NSCLC: A Retrospective Study
14:30 - 14:30 | Author(s): H. Kenmotsu
- Abstract
Loading... -
+
P2.02-032 - Induction Histology-Based Combination Chemotherapy for Elderly Patients with Inoperable Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): G.L. Banna
- Abstract
Loading... -
+
P2.02-033 - The Role of Surgery for Treating Occult N2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Yanada
- Abstract
Loading... -
+
P2.02-034 - Both Induction and Adjuvant Treatment Improve Outcomes of Surgically-Resected IIIA(N2) NSCLC When Compared to Definitive Chemoradiotherapy
14:30 - 14:30 | Author(s): P.J. Villeneuve
- Abstract
Loading... -
+
P2.02-035 - The Advantage of Induction Chemoradiotherapy in Bronchoplastic Procedure for Non Small Cell Lung Cancer Accompanied with Central Disease Region
14:30 - 14:30 | Author(s): H. Sato
- Abstract
Loading... -
+
P2.02-036 - Double Plasty Operation; A Procedure with Pulmonary Arterioplasty and Bronchoplasty against Centrally Located Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): K. Takahashi
- Abstract
Loading... -
+
P2.02-037 - Final Results of Prospective Phase II Study of Adding Erlotinib to Chemoradiation for patients with Stage III Non-Small-Cell Lung Cancer
14:30 - 14:30 | Author(s): R. Komaki
- Abstract
Loading... -
+
P2.02-038 - Surgical Outcome of Stage III A-cN2/pN2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): R. Kamohara
- Abstract
Loading... -
+
P2.02-039 - Intercalated EGFR and Chemotherapy in Locally Advanced NSCLC with EGFR Mutations: Data on 5 Patients and Clinical Study
14:30 - 14:30 | Author(s): F. Griesinger
- Abstract
Loading... -
+
P2.02-040 - Phase 3 Randomized Low-Dose Paclitaxel Chemoradiotherapy Study for Locally Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Lin
- Abstract
Loading... -
+
P2.02-041 - The Impact of Surgical Resection after Concurrent Chemotherapy and High Dose (61 Gy) Radiation in Stage IIIA/N2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Turna
- Abstract
Loading... -
+
P2.02-042 - Surgical Management of Squamous Cell Carcinoma of the Lung: Survival and Functional Outcomes
14:30 - 14:30 | Author(s): J. Chen
- Abstract
Loading... -
+
P2.02-043 - Randomized Ph II Trial of Allogeneic DPV-001 Cancer Vaccine Alone or with Adjuvant for Curatively-Treated Stage III NSCLC
14:30 - 14:30 | Author(s): R.E. Sanborn
- Abstract
Loading... -
+
P2.02-044 - Impact of N2 Extent and Nodal Response on Survival after Trimodal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H.K. Kim
- Abstract
Loading... -
+
P2.02-045 - Prognostic Value of Metabolic FDG-PET Response in Locally Advanced NSCLC: A Literature Review
14:30 - 14:30 | Author(s): C. Dooms
- Abstract
Loading... -
+
P2.02-046 - Prognostic Value of Early Tumor Regression during Chemo-Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Lin
- Abstract
Loading... -
+
P2.02-047 - Association of FDG PET, Complete Pathological Response and Overall Survival in Patients with Pancoast Tumours Treated with Trimodality Therapy
14:30 - 14:30 | Author(s): S. McArthur
- Abstract
Loading... -
+
P2.02-048 - Predictive Factors of Outcome in Locally Advanced NSCLC Patients Treated with Neo-Adjuvant Chemotherapy in Resource-Constrained Settings
14:30 - 14:30 | Author(s): V. J R
- Abstract
Loading... -
+
P2.02-049 - Gender and Risk of Cessation of Oral Vinorelbine in a Randomized Trial of Concurrent Chemoradiation of Locally Advanced NSCLC
14:30 - 14:30 | Author(s): O. Hansen
- Abstract
Loading... -
+
P2.02-050 - Gender and Smoking Influence on Non Small Cell Lung Cancer Histology and Tnm Stage in a Brazilian Population
14:30 - 14:30 | Author(s): R.M. Terra
- Abstract
Loading... -
+
P2.02-051 - Prognostic Value of the Pretreatment Peripheral Blood Markers in Patients with Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): I. Markelić
- Abstract
Loading... -
+
P2.02-052 - Does Delay from Diagnosis to Start of Radiotherapy, or Modified Comorbidity Score Impact Survival in Curatively Treated Non Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J.D. Ruben
- Abstract
Loading... -
+
P2.02-053 - Does the Method of Mediastinal Staging Cause the Mediastinal Nodal Clearance Following Trimodality Therapy?
14:30 - 14:30 | Author(s): J.H. Cho
- Abstract
Loading... -
+
P2.02-054 - Impact of Prognostic Nutrition Index for Induction Chemoradiotherapy Followed by Surgery in Locally Advanced Non-Small Lung Cancers
14:30 - 14:30 | Author(s): J. Soh
- Abstract
Loading... -
+
P2.02-055 - Pathologic Mediastinal Nodal and Metabolic Tumor Response to Predict Overall Survival in Stage IIIA-N2 NSCLC after Neoadjuvant Chemotherapy
14:30 - 14:30 | Author(s): C. Dooms
- Abstract
Loading... -
+
P2.02-056 - FGFR Gene Mutation is an Independent Prognostic Factor in Squamous Non-Small Cell Lung Cancer, and Associated with Lymph Node Metastasis
14:30 - 14:30 | Author(s): L. Jingjing
- Abstract
Loading... -
+
P2.02-057 - The Importance of Adaptive Radiotherapy in the Radical Treatment of Locally Advanced Non Small Cell Lung Cancer
14:30 - 14:30 | Author(s): S. Maric
- Abstract
Loading... -
+
P2.02-058 - Moderately Hypofractionated Radiotherapy in Locally Advanced Non Small Cell Lung Cancer: A Single Institution Retrospective Analysis
14:30 - 14:30 | Author(s): A. Bruni
- Abstract
Loading... -
+
P2.02-059 - New Treatment Strategy in Inoperabl Locoregionally Advanced NSCLC: C Arm Cone Beam CT-GuıDed Selective Intraarterial Chemotherapy
14:30 - 14:30 | Author(s): M. Ozdogan
- Abstract
Loading... -
+
P2.02-060 - SBRT and Sequential Chemotherapy for Stage IIA to IIIA Non-Small Cell Lung Cancer - A Phase I Dose Escalation Study
14:30 - 14:30 | Author(s): D. Von Reibnitz
- Abstract
Loading... -
+
P2.02-061 - Role of MMP-2-1306C/T in Onset of Hematological Toxicity in Lung Cancer Patients Receiving First Line Platinum Based Therapy
14:30 - 14:30 | Author(s): A. Daniele
- Abstract
Loading... -
+
P2.02-062 - Alterations in Pulmonary Function Tests Predict the Development of Radiation-Induced Pneumonitis in Advanced NSCLC
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading...
-
+
P2.03a - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 72
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03a-001 - A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): B. Han
- Abstract
Loading... -
+
P2.03a-002 - Patterns of Chemotherapy Use and Overall Survival (OS) of Patients with Stage IV Squamous Lung Cancer (SCC)
14:30 - 14:30 | Author(s): S.N. Waqar
- Abstract
Loading... -
+
P2.03a-003 - Belinostat in Combination with Carboplatin and Paclitaxel in Patients with Chemotherapy-Naive Metastatic Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): S.N. Waqar
- Abstract
Loading... -
+
P2.03a-004 - Second-line Therapy Improves Overall Survival in Primary Refractory Non Small-Cell Lung Cancer (NSCLC) Patients
14:30 - 14:30 | Author(s): S.I. Rothschild
- Abstract
Loading... -
+
P2.03a-005 - A Study of Endostar Combined with Gemcitabine in the First-Line Treatment of the Elderly Patients with Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): Q. Chen
- Abstract
Loading... -
+
P2.03a-006 - Frequency of 2 Year PFS Milestone in Stage IV NSCLC Patients Treated with First Line Pemetrexed/Platinum and Pemetrexed Maintenance
14:30 - 14:30 | Author(s): J. Macklis
- Abstract
Loading... -
+
P2.03a-007 - Pem/CBP/Bev Followed by Pem/Bev in Hispanic Patients with NSCLC: Outcomes According to Combined Score of TS, ERCC1 and VEGF Expression
14:30 - 14:30 | Author(s): A.F. Cardona
- Abstract
Loading... -
+
P2.03a-008 - Relative Dose Intensity of First-Line Chemotherapy and Overall Survival in Patients With Advanced Non–Small-Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): N. Denduluri
- Abstract
Loading... -
+
P2.03a-009 - Clinical Outcome of Node-Negative Oligometastatic Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Takeda
- Abstract
Loading... -
+
P2.03a-010 - A Randomized Phase II Study of Platinum-Based Chemotherapy +/- Metformin in Chemotherapy-Naïve Advanced Non-Squamous NSCLC
14:30 - 14:30 | Author(s): K.A. Marrone
- Abstract
Loading... -
+
P2.03a-011 - Population Pharmacokinetic/Pharmacodynamic Monitoring of Pemetrexed to Predict Survival in Patients with Advanced NSCLC
14:30 - 14:30 | Author(s): S. Visser
- Abstract
Loading... -
+
P2.03a-012 - Nephrotoxicity in Patients with Advanced NSCLC Receiving Pemetrexed-Based Chemotherapy
14:30 - 14:30 | Author(s): S. Visser
- Abstract
Loading... -
+
P2.03a-013 - Chemotherapy is Beneficial for Octogenarians with Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): H. Koyi
- Abstract
Loading... -
+
P2.03a-014 - A Dose-Finding and Phase 2 Study of Ruxolitinib plus Pemetrexed/Cisplatin for Nonsquamous Non–Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): G. Giaccone
- Abstract
Loading... -
+
P2.03a-015 - Systemic Inflammation Alters Carboplatin Pharmacokinetics Explaining Poor Survival in Advanced Lung Cancer Patients
14:30 - 14:30 | Author(s): B.D.W. Harris
- Abstract
Loading... -
+
P2.03a-016 - Weekly Paclitaxel with 4 Weekly Carboplatin as Salvage Treatment in Advanced Non-Small Cell Lung Cancer- HCG Centre Experience
14:30 - 14:30 | Author(s): S.C. Thungappa
- Abstract
Loading... -
+
P2.03a-017 - Chemotherapy-Induced Nausea and Vomiting (CINV) in Italian Lung Cancer Patients: Assessment by Physician, Nurse and Patient
14:30 - 14:30 | Author(s): S. Carnio
- Abstract
Loading... -
+
P2.03a-018 - A Phase I/II Study of Alisertib, an Oral Aurora Kinase Inhibitor, in Combination with Erlotinib in Patients with Recurrent or Metastatic NSCLC
14:30 - 14:30 | Author(s): J.L. Godwin
- Abstract
Loading... -
+
P2.03a-019 - A Retrospective Analysis Of Nanoparticle Albumin Bound Paclitaxel In Chinese Patients With Recurrent Advanced Non-small Cell Lung Cancer In A Single Center
14:30 - 14:30 | Author(s): Y. Zhu
- Abstract
Loading... -
+
P2.03a-020 - Metronomic Oral Vinorelbine Monotherapy in Elderly Patients with Advanced NCSLC
14:30 - 14:30 | Author(s): K. Tzimopoulos
- Abstract
Loading... -
+
P2.03a-021 - Vinorelbine/Carboplatin vs Gemcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
14:30 - 14:30 | Author(s): A. Dayyoub
- Abstract
Loading... -
+
P2.03a-022 - QOL and Febrile Neutropenia: Japanese Phase 2 Trial of Docetaxel with/out Antiangiogenic Agent in 2nd Line NSCLC
14:30 - 14:30 | Author(s): Y. Omori
- Abstract
Loading... -
+
P2.03a-023 - Induction-Maintenance Treatment Sequence in Non-Squamous Non-Small Cell Lung Cancer (neNSCLC): Pemetrexed vs Vinorelbine-Based Induction
14:30 - 14:30 | Author(s): X. Mielgo Rubio
- Abstract
Loading... -
+
P2.03a-024 - The Clinical Efficacy and Safety of Paclitaxel Liposome on the Patients with Non-Small Cell Lung Cancer: A Meta-Analysis
14:30 - 14:30 | Author(s): X. Hu
- Abstract
Loading... -
+
P2.03a-025 - Randomized, Double-Blind, Phase 3 Study Comparing Biosimilar Candidate ABP 215 with Bevacizumab in Patients with Non-Squamous NSCLC
14:30 - 14:30 | Author(s): N. Thatcher
- Abstract
Loading... -
+
P2.03a-026 - Pemetrexed (Alimta) in Maintenance Therapy of 194 Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): J. Skřičková
- Abstract
Loading... -
+
P2.03a-027 - A Phase I Study of the Non-Receptor Tyrsine Kinase Inhibitor (NKI) Bosutinib in Combination with Pemetrexed in Patients with Advanced Solid Tumors
14:30 - 14:30 | Author(s): N.A. Karim
- Abstract
Loading... -
+
P2.03a-028 - Phase I/II Trial of Carboplatin, nab-Paclitaxel and Bevacizumab for Advanced Non-Squamous Non-Small Cell Lung Cancer: Results of Phase I Part
14:30 - 14:30 | Author(s): S. Ikeo
- Abstract
Loading... -
+
P2.03a-029 - Efficacy and Safety of Combined Carboplatin, Paclitaxel and Bevacizumab for Patients with Stage IIIb and IV Non-Squamous NSCLC
14:30 - 14:30 | Author(s): M. Vaslamatzis
- Abstract
Loading... -
+
P2.03a-030 - nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC: Interim Quality of Life (QoL) Results From ABOUND.sqm
14:30 - 14:30 | Author(s): M. Thomas
- Abstract
Loading... -
+
P2.03a-031 - Metronomic Oral Vinorelbine as First-Line Treatment in Elderly (>65 Year) Patients with Advanced NSCLC
14:30 - 14:30 | Author(s): F. Lumachi
- Abstract
Loading... -
+
P2.03a-032 - Palliative Chemotherapy with Oral Metronomic Vinorelbine in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unsuitable for Chemotherapy
14:30 - 14:30 | Author(s): G.L. Banna
- Abstract
Loading... -
+
P2.03a-033 - Prediction of Response to First Line Treatment for Metastatic Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A.A. Badawy
- Abstract
Loading... -
+
P2.03a-034 - RRM1 - A Prognostic Marker in Advanced NSCLC among Male Smokers Receiving Chemotherapy
14:30 - 14:30 | Author(s): M. Rahouma
- Abstract
Loading... -
+
P2.03a-035 - Down-Regulation of βIII-Tubulin and bFGF Sensitizes Non–Small Cell Lung Carcinoma A549/Taxol Cells Lines to Taxol
14:30 - 14:30 | Author(s): Q. Guo
- Abstract
Loading... -
+
P2.03a-036 - Response of Additional Chemotherapy, since First Line Chemotherapy in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J.H. Chang
- Abstract
Loading... -
+
P2.03a-037 - Prognosis of Advanced Non-Small Cell Lung Cancer (NSCLC) Refractory to First-Line Platinum Chemotherapy
14:30 - 14:30 | Author(s): H.K. Ahn
- Abstract
Loading... -
+
P2.03a-038 - Phase III Trial of Pemetrexed/Carboplatin vs Pemetrexed Only in Chemo-Naïve Elderly Non-SQCC NSCLC Patients Aged ≥ 70
14:30 - 14:30 | Author(s): D.H. Lee
- Abstract
Loading... -
+
P2.03a-039 - ABOUND.70+: Interim Quality of Life (QoL) Results of nab-Paclitaxel/Carboplatin Treatment of Elderly Patients With NSCLC
14:30 - 14:30 | Author(s): J. Weiss
- Abstract
Loading... -
+
P2.03a-040 - Safety and Efficacy of Nab-Paclitaxel for 2nd Line Treatment of Elderly Patients with Stage IV Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Weiss
- Abstract
Loading... -
+
P2.03a-041 - Comparison between Combination and Mono Chemotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Population-Based Study
14:30 - 14:30 | Author(s): Y. Lee
- Abstract
Loading... -
+
P2.03a-042 - Comorbidity as a Prognostic Factor in Elderly Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
14:30 - 14:30 | Author(s): D.S. Sazdanic-Velikic
- Abstract
Loading... -
+
P2.03a-043 - A Retrospective Analysis of the Chemotherapy for 'Very Old' Patients Aged 80 Years and Order with Advanced Lung Cancer
14:30 - 14:30 | Author(s): Y. Tamura
- Abstract
Loading... -
+
P2.03a-044 - Severe Adverse Events Impact Overall Survival (OS) and Costs in Elderly Patients with Advanced NSCLC on Second-Line Therapy
14:30 - 14:30 | Author(s): H. Borghaei
- Abstract
Loading... -
+
P2.03a-045 - Safety of Bevacizumab (B) in Elderly Stage IV Non-Squamous NSCLC Patients Selected by Geriatric Assessment: A Phase II Study
14:30 - 14:30 | Author(s): Ó. Juan
- Abstract
Loading... -
+
P2.03a-046 - Safety and Efficacy Results From ABOUND.70+: nab-Paclitaxel/Carboplatin in Elderly Patients With Advanced NSCLC
14:30 - 14:30 | Author(s): C. Langer
- Abstract
Loading... -
+
P2.03a-047 - Clinical Trial Participation and Outcomes in Non-Small Cell Lung Cancer: Case-Control Study
14:30 - 14:30 | Author(s): A.L. Ortega Granados
- Abstract
Loading... -
+
P2.03a-048 - The CDK4/6 Inhibitor G1T28 Protects Immune Cells from Cisplatin-Induced Toxicity in vivo and Inhibits SCLC Tumor Growth
14:30 - 14:30 | Author(s): I. Guijarro
- Abstract
Loading... -
+
P2.03a-049 - Response to Salvage Chemotherapy Following Exposure to PD-1 Inhibitors in Patients with Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): P.D. Leger
- Abstract
Loading... -
+
P2.03a-050 - Elevated Expression of CCP Genes is Associated with Absolute Chemotherapy Benefit in Early Stage Lung Adenocarcinoma Patients
14:30 - 14:30 | Author(s): P.S. Adusumilli
- Abstract
Loading... -
+
P2.03a-051 - CMTM1_v17 Promotes Chemotherapy Resistance and is Associated with Poor Prognosis in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Si
- Abstract
Loading... -
+
P2.03a-052 - Phase I Study and Pharmacokinetics of Paclitaxel Micelles for Injection in Chinese Patients with Advanced-Stage Malignancies
14:30 - 14:30 | Author(s): M. Shi
- Abstract
Loading... -
+
P2.03a-053 - Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab
14:30 - 14:30 | Author(s): P. Pastina
- Abstract
Loading... -
+
P2.03a-054 - A Single-Arm Phase II Study of Nab-Paclitaxel for Patients with Chemorefractory Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Tanaka
- Abstract
Loading... -
+
P2.03a-055 - Predicting Risk of Chemotherapy-Induced Severe Neutropenia in Lung Patients: A Pooled Analysis of US Cooperative Group Trials
14:30 - 14:30 | Author(s): X. Wang
- Abstract
Loading... -
+
P2.03a-056 - Phase II Trial of Weekly Nab-Paclitaxel for Previously Treated Advanced Non–Small Cell Lung Cancer: KTOSG Trial 1301
14:30 - 14:30 | Author(s): S. Sakata
- Abstract
Loading... -
+
P2.03a-057 - Ligand Mediated Solid Lipid Nanoparticle of Paclitaxel for Effective Management of Bronchogenic Carcinoma
14:30 - 14:30 | Author(s): S. Bhargava
- Abstract
Loading... -
+
P2.03a-058 - Is There a Place for Pemetrexed Rechallenge in Advanced Lung Adenocarcinoma?
14:30 - 14:30 | Author(s): S. Lan
- Abstract
Loading... -
+
P2.03a-059 - LCL161 Increases Paclitaxel-Induced Apoptosis by Degrading cIAP1 and cIAP2 in NSCLC
14:30 - 14:30 | Author(s): C. Yang
- Abstract
Loading... -
+
P2.03a-060 - Favorable Survival of TTF-1 Expression in Pemetrexed Based Treated NSCLC Patients
14:30 - 14:30 | Author(s): C. Steppert
- Abstract
Loading... -
+
P2.03a-061 - Randomized Phase II Trial Comparing Intercalation of Afatinib to Pemetrexed with Pemetrexed Alone after Failure of Platinum Doublet Therapy
14:30 - 14:30 | Author(s): S. Yoon
- Abstract
Loading... -
+
P2.03a-062 - Characterisation and Targeting of the DNA Repair Gene, XRCC6BP1, in Cisplatin Resistant NSCLC
14:30 - 14:30 | Author(s): M.P. Barr
- Abstract
Loading... -
+
P2.03a-063 - Small Molecule Cancer Stemness Inhibitor, BBI608, Restores Cisplatin Sensitivity in Resistant NSCLC
14:30 - 14:30 | Author(s): L. Mac Donagh
- Abstract
Loading... -
+
P2.03a-064 - Inhibition and Exploitation of Aldehyde Dehydrogenase 1 as a Cancer Stem Cell Marker to Overcome Cisplatin Resistant NSCLC
14:30 - 14:30 | Author(s): L. Mac Donagh
- Abstract
Loading... -
+
P2.03a-065 - Lack of Drug-Drug Interaction (DDI) between Necitumumab and Gemcitabine or Cisplatin: A Phase 2, Open-Label, Nonrandomized Study
14:30 - 14:30 | Author(s): A. Chaudhary
- Abstract
Loading... -
+
P2.03a-066 - Pemetrexed(P) in Third and Fourth Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (Non-Squamous)-aNSCLCns
14:30 - 14:30 | Author(s): A.C. Grigorescu
- Abstract
Loading... -
+
P2.03a-067 - Therapy-Related Leukemia after Lung Cancer Chemotherapy
14:30 - 14:30 | Author(s): K. Natori
- Abstract
Loading... -
+
P2.03a-068 - Impact of Platinum/Pemetrexed versus Other Platinum-Based Regimens on Adjuvant Chemotherapy in Resected Adenocarcinoma Lung Cancer
14:30 - 14:30 | Author(s): X. Zhai
- Abstract
Loading... -
+
P2.03a-069 - Effectivenes of Adjuvant Carboplatin-Based Chemotherapy Compared to Cisplatin in Resected Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): V. Couillard-Montminy
- Abstract
Loading... -
+
P2.03a-070 - A Feasibility Study of Adjuvant Chemotherapy with Modified Weekly Nab-Paclitaxel and Carboplatin for Completely Resected NSCLC
14:30 - 14:30 | Author(s): H. Saji
- Abstract
Loading... -
+
P2.03a-071 - Adjuvant Chemotherapy Following Resection of NSCLC: An Audit of 5 Years of Practice and Outcomes in South West Wales
14:30 - 14:30 | Author(s): A.N. Case
- Abstract
Loading... -
+
P2.03a-072 - Interim Results from ABOUND.Sqm: Safety of nab-Paclitaxel/Carboplatin Induction Therapy in Squamous (SCC) NSCLC
14:30 - 14:30 | Author(s): M. McCleod
- Abstract
Loading...
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-001 - A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm+) NSCLC Patients with Brain Metastasis
14:30 - 14:30 | Author(s): Q. Zhou
- Abstract
Loading... -
+
P2.03b-002 - Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): X. Dong
- Abstract
Loading... -
+
P2.03b-003 - Mutation Profile & Histology According to ERS/ATC/IASCL Associated with IPFS to WBI in BM Patients with Recent Adenocarcinoma Lung Cancer
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading... -
+
P2.03b-004 - Factors Associated with Brain Metastasis in Patients with Lung Adenocarcinoma after Surgical Resection
14:30 - 14:30 | Author(s): J. Hung
- Abstract
Loading... -
+
P2.03b-005 - Correlation between Primary Tumor Location and Brain Metastasis Development or Peritumoral Brain Edema in Lung Cancer
14:30 - 14:30 | Author(s): K. Fabian
- Abstract
Loading... -
+
P2.03b-006 - Distinct MR Imaging Features of Metastatic Lesions in Brain with Non-Small Cell Lung Cancer According to EGFR Mutation Status
14:30 - 14:30 | Author(s): Y. Cheng
- Abstract
Loading... -
+
P2.03b-007 - Palliative Whole Brain Radiotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC), the University College London Hospital Experience
14:30 - 14:30 | Author(s): A.J. Ward
- Abstract
Loading... -
+
P2.03b-008 - The Impact of Brain Metastases and Their Treatment on Health Utility Scores in Molecular Subsets of Lung Cancer Patients
14:30 - 14:30 | Author(s): G.M. O'Kane
- Abstract
Loading... -
+
P2.03b-009 - Brain Metastasis and Epidermal Growth Factor Receptor Mutations in Croatian Caucasians with Lung Adenocarcinoma
14:30 - 14:30 | Author(s): K.B. Sreter
- Abstract
Loading... -
+
P2.03b-010 - EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases
14:30 - 14:30 | Author(s): L. Shi
- Abstract
Loading... -
+
P2.03b-011 - Screening for ALK Abnormalities in Central Nervous System Metastases of Non-Small-Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Nicoś
- Abstract
Loading... -
+
P2.03b-012 - A Phase II Study of Etirinotecan Pegol (NKTR-102) in Patients with Refractory Brain Metastases and Advanced Lung Cancer
14:30 - 14:30 | Author(s): S. Nagpal
- Abstract
Loading... -
+
P2.03b-013 - Outcome of Patients with ALK+ NSCLC and Brain Metastases in Relation to Disease Burden and Clinical Management
14:30 - 14:30 | Author(s): L. De Petris
- Abstract
Loading... -
+
P2.03b-014 - Atezolizumab in Advanced NSCLC Patients with Baseline Brain Metastases: A Pooled Cohort Safety Analysis
14:30 - 14:30 | Author(s): R. Lukas
- Abstract
Loading... -
+
P2.03b-015 - Efficacy of the Irreversible ErbB Family Blocker Afatinib in Treatment of an Intracerebral Non-Small Cell Lung Cancer in Mice
14:30 - 14:30 | Author(s): L. Zhu
- Abstract
Loading... -
+
P2.03b-016 - Tesevatinib in NSCLC Patients with EGFR Activating Mutations and Brain Metastases (BM) or Leptomeningeal Metastases (LM)
14:30 - 14:30 | Author(s): D. Berz
- Abstract
Loading... -
+
P2.03b-017 - Differences of Central Nerve System Metastasis during Gefitinib or Erlotinib Therapy in Patients with EGFR-Mutated Lung Adenocarcinoma
14:30 - 14:30 | Author(s): K. Yoshida
- Abstract
Loading... -
+
P2.03b-018 - Clinical Data from the Real World: Efficacy of Crizotinib in Chinese Patients with Advanced ALK+ Non-Small Cell Lung Cancer and Brain Metastases
14:30 - 14:30 | Author(s): S. Wang
- Abstract
Loading... -
+
P2.03b-019 - Comparison of the Efficacy of First-Generation EGFR-TKIs in Brain Metastasis
14:30 - 14:30 | Author(s): N. Aiko
- Abstract
Loading... -
+
P2.03b-020 - EGFR Exon 19 Deletion Mutation Patients Obtain Optimal Survival in Icotinib Treated Non–Small-Cell Lung Cancer Patient with Brain Metastases
14:30 - 14:30 | Author(s): X. Xu
- Abstract
Loading... -
+
P2.03b-021 - Screening for Major Oncogene Alterations in Adenosquamous Lung Carcinoma Using PCR Coupled with Next-Generation and Sanger Sequencing Methods
14:30 - 14:30 | Author(s): X. Shi
- Abstract
Loading... -
+
P2.03b-022 - Outcome in Molecularly Defined NSCLC within the NOWEL Network: The Influence of Sequential 2nd and 3rd Generation TKI in EGFR mt+ and ALK+ pts
14:30 - 14:30 | Author(s): J. Roeper
- Abstract
Loading... -
+
P2.03b-023 - Circulating Tumor DNA (ctDNA)-Based Genomic Profiling of Known Cancer Genes in Lung Squamous Cell Carcinoma (LUSC)
14:30 - 14:30 | Author(s): V.K. Lam
- Abstract
Loading... -
+
P2.03b-024 - microRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer (NSCLC) by Activating MAPK/MEK/ERK Signaling Pathway
14:30 - 14:30 | Author(s): X. Dong
- Abstract
Loading... -
+
P2.03b-025 - Mutation Profile and Histology Subtype According to IASLC/ERS/ATC as Risk Factors for Brain Metastases in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): L. Ramirez-Tirado
- Abstract
Loading... -
+
P2.03b-026 - Next-Generation Sequencing for Molecular Diagnosis of Tumour Specimens from Patients with Advanced Lung Adenocarcinoma
14:30 - 14:30 | Author(s): M.G.O. Fernandes
- Abstract
Loading... -
+
P2.03b-027 - Circulating Free DNA (cfDNA) Analysis from Patients with Advanced Lung Adenocarcinoma
14:30 - 14:30 | Author(s): M.G.O. Fernandes
- Abstract
Loading... -
+
P2.03b-028 - Improved Overall Survival Following Implementation of NGS in Routine Diagnostics of Advanced Lung Cancer in Germany: Results of the NGM
14:30 - 14:30 | Author(s): A. Kostenko
- Abstract
Loading... -
+
P2.03b-029 - Analysis of Genomic Alterations and Heterogeneity in Pulmonary Adenoid Cystic Carcinoma by Next-Generation Sequencing
14:30 - 14:30 | Author(s): M. Li
- Abstract
Loading... -
+
P2.03b-030 - Retrospective Review Clinical Use of a cfDNA Blood Test for Identification of Targetable Molecular Alterations in Patients with Lung Cancer
14:30 - 14:30 | Author(s): H.T. Tran
- Abstract
Loading... -
+
P2.03b-031 - Impact of PD-L1 Status on Clinical Response in SELECT-1: Selumetinib + Docetaxel in KRASm Advanced NSCLC
14:30 - 14:30 | Author(s): P. Jänne
- Abstract
Loading... -
+
P2.03b-032 - The Peculiar Changing Pattern of Serum NSE Acts as an Indicator of Transformation from Adenocarcinoma to SCLC
14:30 - 14:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P2.03b-033 - Clinical Effectiveness of Hybrid Capture-Based Massive Parallel Sequencing in Therapeutic Strategy Planning in Lung Cancer
14:30 - 14:30 | Author(s): A. Belilovski Rozenblum
- Abstract
Loading... -
+
P2.03b-034 - Clinical Relevant Oncogenic Drivers in Advanced Adenocarcinoma Discloses New Therapeutic Targets in Negative EGFR/ALK/KRAS Patients
14:30 - 14:30 | Author(s): J.R. Machado
- Abstract
Loading... -
+
P2.03b-035 - EGFR FISH as Potential Predictor of Necitumumab Benefit with Chemotherapy in Squamous NSCLC: Subgroup Analyses from SQUIRE
14:30 - 14:30 | Author(s): C. Genova
- Abstract
Loading... -
+
P2.03b-036 - Analysis of Potentially Targetable Mutations in 821 Patients with Squamouscell Lung Cancer Undergoing Routine NGS-Based Molecular Diagnostics
14:30 - 14:30 | Author(s): S. Koleczko
- Abstract
Loading... -
+
P2.03b-037 - Prognostic Impact of 1st-Line Treatment and Molecular Testing in Advanced NSCLC in France - Results of the IFCT-PREDICT.amm Study
14:30 - 14:30 | Author(s): J. Cadranel
- Abstract
Loading... -
+
P2.03b-038 - The Diagnostic and Prognostic Value of CSF Cyfra 21-1 in Patients with Leptomeningeal Metastasis of Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): J. Hyun
- Abstract
Loading... -
+
P2.03b-039 - Cell-Free (cf) DNA and cfRNA levels in Plasma of Lung Cancer Patients Indicate Disease Status and Predict Progression
14:30 - 14:30 | Author(s): L.E. Raez
- Abstract
Loading... -
+
P2.03b-040 - NANOG Predicts Poor Outcome in Advanced Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
14:30 - 14:30 | Author(s): S.H. Lee
- Abstract
Loading... -
+
P2.03b-041 - Cerebrospinal Fluid Tumor Cells for Diagnosis of Leptomeningeal Metastases in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): Y. Li
- Abstract
Loading... -
+
P2.03b-042 - MET exon 14 Mutations Encode a Hyperactive Kinase and Therapeutic Target in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): N. Peled
- Abstract
Loading... -
+
P2.03b-043 - Peripheral Blood CD45RA+ CCR7+ Naive T Cells Were Correlated with Prognosis in Non-Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): S. Huang
- Abstract
Loading... -
+
P2.03b-044 - Treatment Outcome and the Role of Primary Tumor Therapy in a Cohort of Patients with Synchronous Oligometastatic NSCLC
14:30 - 14:30 | Author(s): J.C. Ruffinelli
- Abstract
Loading... -
+
P2.03b-045 - Assessment of microRNAs in FFPE Tissue for Prediction of the Effect of Palliative Chemotherapy for Squamous Cell Carcinoma of the Lung
14:30 - 14:30 | Author(s): M. Svaton
- Abstract
Loading... -
+
P2.03b-046 - Clinicopathologic Characteristics, Genetic Variability and Therapeutic Options of RET Rearrangement Patients in Lung Adenocarcinoma
14:30 - 14:30 | Author(s): Z. Song
- Abstract
Loading... -
+
P2.03b-047 - The Clinical Impact of Multiplex ctDNA Gene Analysis in Lung Cancer
14:30 - 14:30 | Author(s): S. Geva
- Abstract
Loading... -
+
P2.03b-048 - Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A.K. Ganti
- Abstract
Loading... -
+
P2.03b-049 - Molecular & Clinical Status of Current Biomarkers: EGFR, ALK, ROS, MET of Lung Cancer in North Indian Patients
14:30 - 14:30 | Author(s): M. Suryavanshi
- Abstract
Loading... -
+
P2.03b-050 - Prognostic Value of HLA-A2 Status in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients
14:30 - 14:30 | Author(s): L. Mezquita
- Abstract
Loading... -
+
P2.03b-051 - TrxR1: A Novel Biomarker Proved to Be Prognostic Factor and Evidence to Provide Newly Treatment Strategies in Metastatic EGFR Wild-Type NSCLC
14:30 - 14:30 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P2.03b-052 - XRCC1 Arg399Gln and Rad51 G135C Gene Polymorphisms in Advanced Lung Adenocarcinoma in Serbia
14:30 - 14:30 | Author(s): J. Spasic
- Abstract
Loading... -
+
P2.03b-053 - Role of KRAS Mutation Status in NSCLC Patients Treated on SWOG S0819, a Phase III Trial of Chemotherapy with or without Cetuximab
14:30 - 14:30 | Author(s): P. Mack
- Abstract
Loading... -
+
P2.03b-054 - Biomarker Predictors in NSCLC
14:30 - 14:30 | Author(s): M. Yahia
- Abstract
Loading... -
+
P2.03b-055 - Survival in Non-Small Cell Lung Cancer (NSCLC) Patients (pts) with Driver Mutations at Sandton Oncology Centre, South Africa
14:30 - 14:30 | Author(s): S.W. Chan
- Abstract
Loading... -
+
P2.03b-056 - Prognostic Value of Neutrophil to Lymphocyte Ratio Was Influenced by Albumin Level
14:30 - 14:30 | Author(s): Z. Ding
- Abstract
Loading... -
+
P2.03b-057 - Diagnostic Value of Tumor Markers in Lung Adenocarcinoma-Associated Cytologically Positive and Negative Pleural Effusions
14:30 - 14:30 | Author(s): C. Su
- Abstract
Loading... -
+
P2.03b-058 - Blood Cell Count Ratios at Diagnosis as Prognostic Markers in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
14:30 - 14:30 | Author(s): E.D. Ricardo
- Abstract
Loading... -
+
P2.03b-059 - Detection of Circulating Tumor Cells Using Multiple mRNA in Situ Hybridization Predicts Metastasis in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): Y. Xu
- Abstract
Loading... -
+
P2.03b-060 - Baseline Skeletal Muscle Index (SMI) Values Are Associated with Biomarkers of Insulin Resistance in Stage IV Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): M. Batus
- Abstract
Loading... -
+
P2.03b-061 - Baseline Neutrophil–Lymphocyte Ratio is Related to Baseline Presence of Brain Metastases and Subsequent Brain Metastases in Stage IV NSCLC
14:30 - 14:30 | Author(s): Y.W. Koh
- Abstract
Loading... -
+
P2.03b-062 - Association of the FAACT Total Score and Subscales with Clinical Characteristics and Survival in Advanced Lung Cancer
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading... -
+
P2.03b-063 - Molecular Profiling in Advanced Non-Small-Cell Lung Cancer: Preliminary Data of an Italian Observational Prospective Study
14:30 - 14:30 | Author(s): E. Gobbini
- Abstract
Loading... -
+
P2.03b-064 - Genomic Profiling in Non Small Cell Lung Cancer: New Hope for Personalized Medicine
14:30 - 14:30 | Author(s): S.C. Thungappa
- Abstract
Loading... -
+
P2.03b-065 - Serum and Bronchoalveolar Lavage Levels of Adiponectin in Advanced Non-Small Cell Lung Cancer: Results of a Prospective Study
14:30 - 14:30 | Author(s): P. Boura
- Abstract
Loading... -
+
P2.03b-066 - Diagnostic Value of Pleural Cytology Together with Pleural CEA and VEGF in Patients with NSCLC and Lung Metastases from Breast Cancer
14:30 - 14:30 | Author(s): F. Lumachi
- Abstract
Loading... -
+
P2.03b-067 - Predictors of Advanced Squamous Cell Lung Cancer Prior to Biopsy; Biological Behavior and Prognostic Factors
14:30 - 14:30 | Author(s): M. Rahouma
- Abstract
Loading... -
+
P2.03b-068 - The Druggable Mutation Landscape of Lung Adenocarcinoma
14:30 - 14:30 | Author(s): A. Gupta
- Abstract
Loading... -
+
P2.03b-069 - LKB1 Loss is a Novel Determinant of MEK Sensitivity Due to Alterations in AKT/FOXO3 Signaling
14:30 - 14:30 | Author(s): T. Yamada
- Abstract
Loading... -
+
P2.03b-070 - Establishment of Organoid Cell Lines from Lung Squamous Cell Carcinoma
14:30 - 14:30 | Author(s): R. Shi
- Abstract
Loading... -
+
P2.03b-071 - Therapeutic Targeting of the Phosphatidylinositol-3 Kinase Pathway in Lung Squamous Cell Carcinoma
14:30 - 14:30 | Author(s): R. Shi
- Abstract
Loading... -
+
P2.03b-072 - Resistance to BET Inhibitors in Lung Adenocarcinoma is Mediated through a MYC Independent Mechanism
14:30 - 14:30 | Author(s): J.B. Calder
- Abstract
Loading... -
+
P2.03b-073 - High Concordance of Somatic SNVs between Tumor-Only and Tumor-Normal Testing: Implications for Clinical Practice
14:30 - 14:30 | Author(s): X. Ran
- Abstract
Loading... -
+
P2.03b-074 - NSCLC Homing Nanoparticles Selectively Transfect Lung Cancer
14:30 - 14:30 | Author(s): G. Holt
- Abstract
Loading... -
+
P2.03b-075 - PD-1 Protein Expression Predicts Survival in Resected Adenocarcinomas of the Lung
14:30 - 14:30 | Author(s): B. Zaric
- Abstract
Loading... -
+
P2.03b-076 - MAP2K1 Mutations in NSCLC: Clinical Presentation and Co-Occurrence of Additional Genetic Aberrations
14:30 - 14:30 | Author(s): A. Holzem
- Abstract
Loading... -
+
P2.03b-077 - EGFR/ALK+ Patient-Derived Xenografts from Advanced NSCLC for TKI Drug Selection & Resistance Development: The REAL-PDX Study
14:30 - 14:30 | Author(s): M. Cabanero
- Abstract
Loading... -
+
P2.03b-078 - MET Gene Amplification and Overexpression in Chinese NSCLC Patients without EGFR Mutations
14:30 - 14:30 | Author(s): Z. Song
- Abstract
Loading... -
+
P2.03b-079 - Decreased Expression of miR-125a-3p is Associated with the Clinical Outcome of Non-Small Cell Lung Cancer Patients
14:30 - 14:30 | Author(s): C. Wu
- Abstract
Loading... -
+
P2.03b-080 - A Comprehensive Test of Cancer Treatment-Related Genes for the Clinical Samples of Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): Y. Inoue
- Abstract
Loading... -
+
P2.03b-081 - Comparison of Genomic Alterations Derived from Matched Tumor Tissue and Liquid Biopsy
14:30 - 14:30 | Author(s): J. Müller-Eisert
- Abstract
Loading... -
+
P2.03b-082 - AQP11 as a Novel Factor of Lung Cancer Cell Resistance to Cisplatin
14:30 - 14:30 | Author(s): J. Evans
- Abstract
Loading... -
+
P2.03b-083 - Soluble Angiogenic Factors as Predictive Biomarkers of Response to Docetaxel plus Nintedanib as Second Line Therapy in NSCLC
14:30 - 14:30 | Author(s): D. Lee-Cervantes
- Abstract
Loading... -
+
P2.03b-084 - Profiling of Eph Signaling in Malignant Pleural Effusions- Identification of Therapy Approaches and Associated Biomarkers
14:30 - 14:30 | Author(s): M. Novak
- Abstract
Loading... -
+
P2.03b-085 - Programmed Cell Death Ligand 1 (PD-L1) Expression in Stage II and III Lung Adenocarcinomas
14:30 - 14:30 | Author(s): H. Uruga
- Abstract
Loading... -
+
P2.03b-086 - High Expression of PDL-1 Correlates with Pleomorphic Features in Non-Small Cell Lung Carcinomas
14:30 - 14:30 | Author(s): F. Kwong
- Abstract
Loading... -
+
P2.03b-087 - PD-L1 Expression in Adenosquamous Lung Carcinoma and the Comparison with the Other Common Variants of Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): X. Shi
- Abstract
Loading... -
+
P2.03b-088 - PET-CT with 68Ga-RGD as Biomarker of Response to Nintedanib plus Docetaxel as Second Line Therapy in NSCLC
14:30 - 14:30 | Author(s): O. Arrieta
- Abstract
Loading... -
+
P2.03b-089 - CD1C in Lung Adenocarcinoma: Prognosis and Cellular Origin
14:30 - 14:30 | Author(s): C. Zhu
- Abstract
Loading... -
+
P2.03b-090 - A CTLA-4 Antagonizing DNA Aptamer with Anti-Tumor Effect
14:30 - 14:30 | Author(s): B. Huang
- Abstract
Loading... -
+
P2.03b-091 - CD47 Promotes Tumor Invasion and Metastasis in Non-small Cell Lung Cancer
14:30 - 14:30 | Author(s): H. Zhao
- Abstract
Loading... -
+
P2.03b-092 - Predictive and Prognostic Effect of Circulating Tumor Cells in Non-Small Cell Lung Cancer Treated with Targeted Therapy
14:30 - 14:30 | Author(s): C. Su
- Abstract
Loading... -
+
P2.03b-093 - Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories
14:30 - 14:30 | Author(s): T. Forshew
- Abstract
Loading... -
+
P2.03b-094 - Prognostic Value of Serum Carcinoembryonic Antigen during Conventional Chemotherapy in Advanced (Non-)Small Cell Lung Cancer
14:30 - 14:30 | Author(s): C. De Jong
- Abstract
Loading... -
+
P2.03b-095 - Retrospective Analysis of Correlation between ACEIs/ARBs and Clinical Outcome in Lung Cancer Patients with Bevacizumab-Based Chemotherapy
14:30 - 14:30 | Author(s): S. Okawa
- Abstract
Loading... -
+
P2.03b-096 - Utilisation of a Novel 3D Culture Technology for the Assessment of Chemo-Resistance in Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): S. Ryan
- Abstract
Loading... -
+
P2.03b-097 - Prognostic Factors for Overall Survival among Patients with Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
14:30 - 14:30 | Author(s): K. Verleger
- Abstract
Loading... -
+
P2.03b-098 - Comparison of Digital PCR, Ion Proton with ARMS-PCR in Tumor Tissue and Plasma of NSCLC Patients
14:30 - 14:30 | Author(s): J. Gu
- Abstract
Loading...
-
+
P2.04 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Mesothelioma/Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Presentations: 54
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.04-001 - A Comparative Analysis of Long-Term Outcome of Thymoma between Video-Assisted Surgery and Open Resection from Multi-Center Study Data
14:30 - 14:30 | Author(s): S.K. Hwang
- Abstract
Loading... -
+
P2.04-002 - The Efficacy of Postoperative Radiotherapy against Thymic Epithelial Tumors According to Masaoka Staging and WHO Classification
14:30 - 14:30 | Author(s): K. Obayashi
- Abstract
Loading... -
+
P2.04-003 - Chemotherapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort
14:30 - 14:30 | Author(s): C. Merveilleux Du Vignaux
- Abstract
Loading... -
+
P2.04-004 - Thymectomy without Definitive Diagnosis Could Be Feasible in Patients with Suspicious of Thymic Epithelial Tumor
14:30 - 14:30 | Author(s): S. Hakiri
- Abstract
Loading... -
+
P2.04-005 - WHO Classification and IASLC/ITMIG Staging Proposal in Thymic Tumors: Real-Life Assessment
14:30 - 14:30 | Author(s): A. Meurgey
- Abstract
Loading... -
+
P2.04-006 - Updated Incidence of Thymic Epithelial Tumors (TET) in France and Clinical Presentation at Diagnosis
14:30 - 14:30 | Author(s): M.V. Bluthgen
- Abstract
Loading... -
+
P2.04-007 - Role of F-18-Choline Petscan in Recurrence of Thymic Epithelial Tumors (TET)
14:30 - 14:30 | Author(s): M.V. Bluthgen
- Abstract
Loading... -
+
P2.04-008 - Diagnostic Performance of PET-CT for Anterior Mediastinal Lesions - The DECiMaL Study
14:30 - 14:30 | Author(s): C. Proli
- Abstract
Loading... -
+
P2.04-009 - Tumor Size Did Not Affect Masaoka Staging as Predictors of Recurrence in Thymoma
14:30 - 14:30 | Author(s): Y. Tseng
- Abstract
Loading... -
+
P2.04-010 - Survival after Surgery and Radiotherapy for Thymic Epithelial Tumours: A Single-Centre Experience from the United Kingdom
14:30 - 14:30 | Author(s): H. Ariyaratne
- Abstract
Loading... -
+
P2.04-011 - Tumours of the Thymus: Northern Ireland 11 Year Experience
14:30 - 14:30 | Author(s): A. Papafili
- Abstract
Loading... -
+
P2.04-012 - A Risk of Death from a Second Cancer Following Complete Resection of Thymoma
14:30 - 14:30 | Author(s): M. Hamaji
- Abstract
Loading... -
+
P2.04-013 - Prognosis Factors and Survival Analysis in Thymic Epithelial Tumors
14:30 - 14:30 | Author(s): L. Del Carpio
- Abstract
Loading... -
+
P2.04-014 - Retrospective Study of Pleuropneumonectomy for Thymoma with Dissemination
14:30 - 14:30 | Author(s): S. Oh
- Abstract
Loading... -
+
P2.04-015 - Thymoma and Thymic Carcinoma - Our Experience
14:30 - 14:30 | Author(s): J. Kulísková
- Abstract
Loading... -
+
P2.04-016 - Is FDG-PET Useful for Distinguishing between Thymic Epithelial Tumors and Malignant Lymphoma?
14:30 - 14:30 | Author(s): H. Sakamaki
- Abstract
Loading... -
+
P2.04-017 - Prognostic Relevance of PD-1/PD-L1 Pathway in Thymic Malignancies with Combined Immunohystochemical and Biomolecular Approach
14:30 - 14:30 | Author(s): R. Berardi
- Abstract
Loading... -
+
P2.04-018 - Comprehensive Copy Number Alteration and Gene Expression Analysis of Surgically Resected Thymic Carcinoma
14:30 - 14:30 | Author(s): T. Nakanishi
- Abstract
Loading... -
+
P2.04-019 - A Peripheral Immune Signature Associated with Clinical Activity of Sunitinib in Thymic Carcinoma
14:30 - 14:30 | Author(s): Y. Tomita
- Abstract
Loading... -
+
P2.04-020 - Expression Patterns and Prognostic Value of PD-L1 and PD-1 in Thymoma and Thymic Carcinoma
14:30 - 14:30 | Author(s): D. Owen
- Abstract
Loading... -
+
P2.04-021 - Role of Adjuvant Radiotherapy and Prognostic Factor Analysis in Thymic Malignancies: A Retrospective Analysis of 129 Consecutive Patients
14:30 - 14:30 | Author(s): A. Bruni
- Abstract
Loading... -
+
P2.04-022 - Impact of Metastasis Site for Survival of Patients with Advanced Thymic Epithelial Tumors
14:30 - 14:30 | Author(s): X. Yu
- Abstract
Loading... -
+
P2.04-023 - Rare Frequency of Gene Variation and Survival Analysis in Thymic Epithelial Tumors
14:30 - 14:30 | Author(s): Z. Song
- Abstract
Loading... -
+
P2.04-024 - Thymic Epithelial Tumors and Radiotherapy Results
14:30 - 14:30 | Author(s): S. Sarihan
- Abstract
Loading... -
+
P2.04-025 - Recombinant Human Endostatin and/or Cisplatin in Treatment of Malignant Hydrothorax and Ascites: A Multicenter Randomized Study
14:30 - 14:30 | Author(s): S. Qin
- Abstract
Loading... -
+
P2.04-026 - Expression Patterns of PD-L1 in Esophageal Adenocarcinomas: Comparison between Primary Tumors and Metastases
14:30 - 14:30 | Author(s): B. Dislich
- Abstract
Loading... -
+
P2.04-027 - Targeting Adenosine A2B Receptor for Modulation of Tumor Microenvironment, Primary Tumor Growth, and Lung Metastasis
14:30 - 14:30 | Author(s): J. Evans
- Abstract
Loading... -
+
P2.04-028 - Cone-Beam CT Virtual Navigation-Guided Percutaneous Needle Biopsy of Suspicious Pleural Metastasis: Initial Experience
14:30 - 14:30 | Author(s): H. Lim
- Abstract
Loading... -
+
P2.04-029 - Primary Pulmonary Sarcoma: Risks and Optimal Surgical Treatment Options
14:30 - 14:30 | Author(s): Y. Yamada
- Abstract
Loading... -
+
P2.04-030 - Airway Intervention in the Management of Low Grade Malignant Bronchogenic Neoplasms
14:30 - 14:30 | Author(s): A.A.L. Hsu
- Abstract
Loading... -
+
P2.04-031 - Predictors of Pathological Complete Response (TRG=1) among Esophageal Cancer Cases; NCI Pooled Data
14:30 - 14:30 | Author(s): M. Rahouma
- Abstract
Loading... -
+
P2.04-032 - Pulmonary Sarcomatoid Carcinoma (PSC): Experience of 45 Patients at a Comprehensive Cancer Center
14:30 - 14:30 | Author(s): P.P. Patel
- Abstract
Loading... -
+
P2.04-033 - Primary Salivary Gland Tumors of the Lung: A Systematic Review and Pooled Analysis
14:30 - 14:30 | Author(s): P.K. Garg
- Abstract
Loading... -
+
P2.04-034 - SPARC/β-Tubulin III Expressions for Clinical Outcomes of ESCC Patients Receiving Nab-Paclitaxel plus DDP Neoadjuvant Chemotherapy
14:30 - 14:30 | Author(s): Y. Fan
- Abstract
Loading... -
+
P2.04-035 - Surgical Perplexities in a Rare Case of Symptomatic Mediastinal Lymphangioma
14:30 - 14:30 | Author(s): K. Ong
- Abstract
Loading... -
+
P2.04-036 - Giant Primary Dedifferentiated Liposarcoma of the Anterior Mediastinum: An Extremely Rare Occurrence
14:30 - 14:30 | Author(s): L. Ventura
- Abstract
Loading... -
+
P2.04-037 - Solitary Fibrous Tumor of the Pleura Associated with Severe Hypoglicemia: The Doege-Potter Syndrome
14:30 - 14:30 | Author(s): L. Ventura
- Abstract
Loading... -
+
P2.04-038 - Primary Pulmonary Meningioma: Rare Tumour with Malignant Potential
14:30 - 14:30 | Author(s): K. Ong
- Abstract
Loading... -
+
P2.04-039 - Long-Term Risk of Recurrence in Benign Pleural Solitary Fibrous Tumors: A Single Institution Review
14:30 - 14:30 | Author(s): G. Woodard
- Abstract
Loading... -
+
P2.04-040 - Pleural Effusion Characteristics and Relationship with Outcomes in Cancer Patients
14:30 - 14:30 | Author(s): I. Bonta
- Abstract
Loading... -
+
P2.04-041 - Two Cases of Pulmonary Schwannoma
14:30 - 14:30 | Author(s): T. Ii
- Abstract
Loading... -
+
P2.04-042 - Epithelial-Myoepithelial Tumour of Unknown Origin: An Interesting Case Report with Unexpected Outcome
14:30 - 14:30 | Author(s): N. Alevizopoulos
- Abstract
Loading... -
+
P2.04-043 - Squamous Cell Carcinoma Arising from the Pleura. An Interesting Case Report
14:30 - 14:30 | Author(s): N. Alevizopoulos
- Abstract
Loading... -
+
P2.04-044 - Mediastinal Neurogenic Tumors: Histopathological Characteristics and Surgical Treatment in a Single-Institutional Experience
14:30 - 14:30 | Author(s): F. Caushi
- Abstract
Loading... -
+
P2.04-045 - Management of Malignant Pleural Effusions: Ten Years Experience of a Single Center
14:30 - 14:30 | Author(s): F. Caushi
- Abstract
Loading... -
+
P2.04-046 - A Rare Case of Pleuro-Pulmonary Epitheliod Hemangioendothelioma
14:30 - 14:30 | Author(s): D. Loizzi
- Abstract
Loading... -
+
P2.04-047 - A Rare Case of Extramedullary Plasmacytoma Occurring in the Posterior Mediastinum
14:30 - 14:30 | Author(s): R. Quercia
- Abstract
Loading... -
+
P2.04-048 - Sarcomatoid Carsinoma of Lung
14:30 - 14:30 | Author(s): B.E. Komurcuoglu
- Abstract
Loading... -
+
P2.04-049 - Treatment for Three Cases Tracheal Carcinoma of Low-Grade Malignancy
14:30 - 14:30 | Author(s): Y. Oshima
- Abstract
Loading... -
+
P2.04-050 - Giant Solitary Fibrous Tumor of the Pleura Saved by Biopsy and Following Extended Resection: A Long Term Surviving Case
14:30 - 14:30 | Author(s): J. Zhang
- Abstract
Loading... -
+
P2.04-051 - Palliative Treatment of Dysphagia Syndrome in Patients with Gastroesophageal Cancer
14:30 - 14:30 | Author(s): A.V. Kasatov
- Abstract
Loading... -
+
P2.04-052 - Promoter Hypermethylation of DNA Mismatch Repair Gene hMLH1 of Lung Cancer in Chromate-Exposed Workers
14:30 - 14:30 | Author(s): M. Tsuboi
- Abstract
Loading... -
+
P2.04-053 - Surgery of Multiple Lung Metastases in Patients with Sarcomas and Epithelial Tumors
14:30 - 14:30 | Author(s): E. Smolenov
- Abstract
Loading... -
+
P2.04-054 - Pleural CEA and C-Reactive Protein in Patients with Lung Metastases and Malignant Pleural Effusion. A Prospective Case-Control Study
14:30 - 14:30 | Author(s): F. Lumachi
- Abstract
Loading...
first
prev
